(Medivir)—JNJ will provide a pre-recorded webcast of the presentation from EASL re Simeprevir (TMC435) phase-3 data at 8:30 am ET tomorrow: http://finance.yahoo.com/news/janssen-johnson-johnson-webcast-presentation-210000655.html